Related Experiment Videos
Persistent vulvovaginal candidiasis: systemic treatment with oral fluconazole
1II Clinics of Obstetrics and Gynecology, University of Rome, La Sapienza, Italy.
Clinical and Experimental Obstetrics & Gynecology
|January 1, 1994
Abstract:
52 patients affected by persistent vulvovaginal candidiasis underwent systemic therapy with oral Fluconazole at a dose of 150 mg once a week for 3 weeks. 31 (59.61%) patients were cured at the first control after therapy. Of the remaining 21 patients, 4 (7.69%) were lost at follow-up and 17 (32.69%) underwent a second cycle of systemic therapy with complete recovery confirmed at the further controls. The overall percentage of recoveries was equal to 92.30%. The results suggest that Fluconazole is very effective in mycotic vulvovaginitis with irrelevant side effects.